lactic acid has been researched along with Mesothelioma in 3 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Mesothelioma: A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Combined treatment based on cisplatin-loaded Poly(D,L-lactic-co-glicolic)acid (PLGA) nanoparticles (NP-C) plus the NSAID piroxicam was used as novel treatment for mesothelioma to reduce side effects related to cisplatin toxicity." | 7.81 | Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells. ( Aruta, MG; Baldi, A; Barba, V; Crispi, S; Diano, N; Favicchia, I; Menale, C; Mita, DG; Nicolucci, C; Piccolo, MT, 2015) |
"Combined treatment based on cisplatin-loaded Poly(D,L-lactic-co-glicolic)acid (PLGA) nanoparticles (NP-C) plus the NSAID piroxicam was used as novel treatment for mesothelioma to reduce side effects related to cisplatin toxicity." | 3.81 | Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells. ( Aruta, MG; Baldi, A; Barba, V; Crispi, S; Diano, N; Favicchia, I; Menale, C; Mita, DG; Nicolucci, C; Piccolo, MT, 2015) |
"Biphasic malignant pleural mesothelioma (MPM) is the second most common histotype of MPM." | 1.42 | Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells. ( Cilli, M; Daga, A; Manente, AG; Moro, L; Nilsson, S; Pinton, G; Rinaldi, M; Zonca, S, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Menale, C | 2 |
Piccolo, MT | 2 |
Favicchia, I | 1 |
Aruta, MG | 1 |
Baldi, A | 1 |
Nicolucci, C | 1 |
Barba, V | 1 |
Mita, DG | 2 |
Crispi, S | 2 |
Diano, N | 1 |
Mayol, L | 1 |
Serri, C | 1 |
Mita, L | 1 |
Giarra, S | 1 |
Forte, M | 1 |
Saija, A | 1 |
Biondi, M | 1 |
Manente, AG | 1 |
Pinton, G | 1 |
Zonca, S | 1 |
Cilli, M | 1 |
Rinaldi, M | 1 |
Daga, A | 1 |
Nilsson, S | 1 |
Moro, L | 1 |
3 other studies available for lactic acid and Mesothelioma
Article | Year |
---|---|
Efficacy of piroxicam plus cisplatin-loaded PLGA nanoparticles in inducing apoptosis in mesothelioma cells.
Topics: Apoptosis; Cell Line, Tumor; Cisplatin; Drug Carriers; Drug Combinations; Humans; Lactic Acid; Mesot | 2015 |
Curcumin loaded PLGA-poloxamer blend nanoparticles induce cell cycle arrest in mesothelioma cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Che | 2015 |
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Basigin; Cell Line, Tumor; Cell Proliferation; Estrogen Re | 2015 |